LeMaitre Vascular Price to Sales Ratio 2010-2025 | LMAT
Historical PS ratio values for LeMaitre Vascular (LMAT) over the last 10 years. The current P/S ratio for LeMaitre Vascular as of June 04, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| LeMaitre Vascular P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-06-05 | 83.40 | 8.41 | |
| 2025-03-31 | 83.70 | $9.92 | 8.44 |
| 2024-12-31 | 91.69 | $9.67 | 9.48 |
| 2024-09-30 | 92.30 | $9.41 | 9.81 |
| 2024-06-30 | 81.59 | $9.12 | 8.95 |
| 2024-03-31 | 65.67 | $8.89 | 7.39 |
| 2023-12-31 | 56.04 | $8.63 | 6.49 |
| 2023-09-30 | 53.64 | $8.30 | 6.46 |
| 2023-06-30 | 66.08 | $7.95 | 8.31 |
| 2023-03-31 | 50.44 | $7.62 | 6.62 |
| 2022-12-31 | 44.97 | $7.30 | 6.16 |
| 2022-09-30 | 49.39 | $7.29 | 6.78 |
| 2022-06-30 | 44.28 | $7.28 | 6.08 |
| 2022-03-31 | 45.05 | $7.32 | 6.16 |
| 2021-12-31 | 48.57 | $7.25 | 6.70 |
| 2021-09-30 | 51.23 | $7.24 | 7.07 |
| 2021-06-30 | 58.76 | $7.27 | 8.08 |
| 2021-03-31 | 46.87 | $6.55 | 7.15 |
| 2020-12-31 | 38.82 | $6.33 | 6.14 |
| 2020-09-30 | 31.11 | $5.98 | 5.21 |
| 2020-06-30 | 25.17 | $5.63 | 4.47 |
| 2020-03-31 | 23.67 | $5.86 | 4.04 |
| 2019-12-31 | 34.03 | $5.78 | 5.89 |
| 2019-09-30 | 32.27 | $5.70 | 5.67 |
| 2019-06-30 | 26.35 | $5.46 | 4.83 |
| 2019-03-31 | 29.10 | $5.34 | 5.45 |
| 2018-12-31 | 22.13 | $5.21 | 4.24 |
| 2018-09-30 | 36.17 | $5.12 | 7.07 |
| 2018-06-30 | 31.20 | $5.16 | 6.05 |
| 2018-03-31 | 33.70 | $5.11 | 6.59 |
| 2017-12-31 | 29.56 | $5.05 | 5.85 |
| 2017-09-30 | 34.68 | $4.96 | 7.00 |
| 2017-06-30 | 28.89 | $4.93 | 5.86 |
| 2017-03-31 | 22.75 | $4.82 | 4.72 |
| 2016-12-31 | 23.35 | $4.67 | 5.00 |
| 2016-09-30 | 18.25 | $4.58 | 3.99 |
| 2016-06-30 | 13.09 | $4.40 | 2.97 |
| 2016-03-31 | 14.20 | $4.32 | 3.28 |
| 2015-12-31 | 15.73 | $4.31 | 3.65 |
| 2015-09-30 | 11.08 | $4.29 | 2.58 |
| 2015-06-30 | 10.93 | $4.25 | 2.57 |
| 2015-03-31 | 7.57 | $4.25 | 1.78 |
| 2014-12-31 | 6.87 | $4.26 | 1.61 |
| 2014-09-30 | 6.15 | $4.30 | 1.43 |
| 2014-06-30 | 7.36 | $4.28 | 1.72 |
| 2014-03-31 | 7.15 | $4.20 | 1.70 |
| 2013-12-31 | 7.07 | $4.11 | 1.72 |
| 2013-09-30 | 5.89 | $3.91 | 1.50 |
| 2013-06-30 | 5.73 | $3.82 | 1.50 |
| 2013-03-31 | 5.40 | $3.72 | 1.45 |
| 2012-12-31 | 4.98 | $3.63 | 1.37 |
| 2012-09-30 | 5.54 | $3.52 | 1.58 |
| 2012-06-30 | 5.16 | $3.55 | 1.45 |
| 2012-03-31 | 5.04 | $3.57 | 1.41 |
| 2011-12-31 | 5.05 | $3.60 | 1.40 |
| 2011-09-30 | 5.28 | $3.65 | 1.45 |
| 2011-06-30 | 5.99 | $3.59 | 1.67 |
| 2011-03-31 | 5.75 | $3.53 | 1.63 |
| 2010-12-31 | 5.70 | $3.48 | 1.64 |
| 2010-09-30 | 5.93 | $3.44 | 1.72 |
| 2010-06-30 | 4.71 | $3.43 | 1.37 |
| 2010-03-31 | 3.79 | $3.35 | 1.13 |
| 2009-12-31 | 4.21 | $3.21 | 1.31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.865B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.380B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.233B | 23.84 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 55.70 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |